AI Method Developed to Efficiently Identify and Count Viruses Used in Vaccine and Gene Therapy Production

Researchers have introduced a new artificial intelligence-based method to identify and count specific viruses with greater efficiency than traditional techniques. This advancement holds potential applications in areas such as pharmaceutical biomanufacturing, where the use of certain viruses plays a critical role.

The newly developed approach leverages AI tools to streamline the process of detecting and quantifying target viruses, which are often used in the production of vaccines and gene therapies. By improving accuracy and speed, this methodology could enhance virus tracking capabilities within industries that rely on these biological agents for large-scale production. The research highlights how AI can address challenges in monitoring these “good” viruses, which are essential to various biotechnological processes.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 23, 2026

Author

GOAI